The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Epidemiology, clinical manifestations, and management of pandemic novel Influenza A (H1N1)

대유행 신종인플루엔자 A (H1N1)의 역학, 임상 소견 및 치료

Kim, Woo-Joo
김우주

  • Published : 20090800
⟨ Previous Next ⟩

Abstract

Since the first case with swine origin influenza A (H1N1) infection has been described in Mexico and the United States in April 2009, novel influenza A (H1N1) virus has been spread to all over the world. WHO has officially declared the outbreak to be an influenza pandemic by 11 June. The number of human cases and death of pandemic A (H1N1) 2009 is still increasing substantially in many countries with widespread community transmission. The natural course of novel influenza A (H1N1) still appears to be generally mild and mostly recovered. It predominantly affects children and young adults with relative sparing of older age groups, supporting a theory that older people have some cross-reactive antibodies to novel influenza A (H1N1) from previous infection or immunization. People with chronic medical conditions and pregnancy are more likely to be hospitalized with or dead from the novel influenza A (H1N1). Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended mainly for all hospitalized patients with novel influenza (H1N1) and patients who are at higher risk for seasonal influenza complications. Continued pandemic preparedness, flexible response and careful monitoring are essential because influenza viruses are unpredictable. This article reviews the current epidemiology, clinical manifestations, and management of pandemic novel influenza A (H1N1).

Keywords

References

  1. WHO. Influenza-like illness in the United States and Mexico. 24 April 2009
  2. WHO. World now at the start of 2009 influenza pandemic. 11 June 2009
  3. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197-201, 2009⨀Ā삟?⨀ऄ돀類?⨀塨?⨀䃣⨀ꡪ?⨀댐䡑ࠄ⣡̀倀胅?⨀ȀᘀĀ졦?⨀㣢Ȁ倀悼?⨀ȀᘀĀ⁧?⨀샢܀倀㡦?⨀ఐ܀Ā硧?⨀䣣܀倀큥?⨀ఐ܀Ā큧?⨀탣܀倀桥?⨀ఐ܀Ā⡨?⨀壤Ȁ倀e?⨀ȀᘀĀ聨?⨀냡紅倀顤?⨀ȁᘀĀ𪎖⨀Ā倀つ?⨀ȀᘀĀど?⨀낗䒳က倀ꁣ?⨀ᜒကĀ衩?⨀㢘䒳Ȁ倀㡣?⨀ȀᘀĀ?⨀삘䒳Ѐ倀큢?⨀ȀᘀĀ㡪?⨀餂돀類?⨀塨?⨀䃣⨀ᢻ?⨀䤀대⥫̄Ѐ㄀대롪?⨀꩑ࠄ섂̀￿￿Ā㤀대k?⨀꩑ࠄ佄䍉偁剔䥎䙏န﾿缀㄀대に?⨀꩑ࠄ聪?⨀넀대桫?⨀띑ࠄ?⨀䃣⨀̀̀耀 ㌀띑ࠄ?⨀聫?⨀ĀᘀԀ䡫?⨀ఀ Ԁᡫ?⨀Ȁ᠀Ԁ돐顫?⨀⨀⨀䃣⨀̀̀耀　㈀鹑ࠄ顬?⨀ȈᘀĀ https://doi.org/10.1126/science.1176225
  4. Zimmer SM, Burke DS. Historical perspective—emergence of influenza A (H1N1) viruses. N Engl J Med 361:279-285, 2009 https://doi.org/10.1056/NEJMra0904322
  5. WHO. Pandemic (H1N1) 2009 - update 58. July 6, 2009
  6. WHO. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection. July 16, 2009
  7. WHO. New influenza A (H1N1) virus: global epidemiological situation, 19 June 2009. Weekly Epidemiological Record 84:249-256, 2009
  8. WHO. Pandemic (H1N1) 2009 briefing note 4. July 24 2009
  9. CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58:521-524, 2009
  10. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C. WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a novel strain of influenza A (H1N1): early findings. Science 324:1557-1561, 2009 https://doi.org/10.1126/science.1176062
  11. Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill 14:19227, 2009
  12. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, Fraser C, Ferguson NM, Ghani AC. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 339:b2840, 2009 https://doi.org/10.1136/bmj.b2840
  13. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Hiroshi Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 (published online Jul 13) https://doi.org/10.1038/nature08260
  14. Senanayake SN. Swine flu update: bringing home the bacon. MJA 191:1-3, 2009
  15. WHO. Influenza A(H1N1) - update 42. 3 June 2009
  16. Kaufman MA, Duke GJ, McGain F, French C, Aboltins C, Lane G, Gutteridge GA. Life-threatening respiratory failure from H1N1 influenza 09 (human swine influenza). MJA 191:214-216, 2009
  17. CDC. Neurologic complications associated with novel influenza A (H1N1) virus infection in children--Dallas, Texas, May 2009. MMWR 58:773-778, 2009
  18. Press release #42-09: community transmission of H1N1 flu appears to decline in New York City. New York City Department of Health and Mental Hygiene, 2009. (http://www.nyc.gov/html/doh/ html/pr2009/pr042-09.shtml; accessed June 2009)
  19. CDC. Interim guidance for screening for swine-origin influenza A (H1N1) by state and local health departments, hospitals, and clinicians in regions with few or no reported cases of swine influenza A (H1N1). 2009
  20. CDC. Interim guidance on specimen collection, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection. 2009
  21. Ginochio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, Lotlikar M, Kowerska M, Becker G, Korologos D, de Geronimo M, Crawford JM. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 45:191-195, 2009 https://doi.org/10.1016/j.jcv.2009.06.005
  22. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009 Jun 29 [Epub ahead of print] https://doi.org/10.1056/NEJMc0904264
  23. Reuters. Roche finds 1st case of H1N1 resistance to Tamiflu. June 29, 2009
  24. Reuters. UPDATE 2-Japan finds first case of H1N1 resistant to Tamiflu. July 2, 2009
  25. CDC. Interim guidance on antiviral recommendations for patients with confirmed or suspected swine influenza A (H1N1) virus infection and close contacts. 2009
  26. CDC. Interim guidance—pregnant women and swine influenza: considerations for clinicians. 2009
  27. CDC. Novel influenza A(H1N1) virus infections among healthcare personnel - United States, April-May 2009. MMWR 58: 641-645, 2009